Skip to Main Content
  • Community
Try STAT+ TODAY
STAT
  • Log In
  • Try STAT+ Today
  • My Account
  • Billing
  • Log Out
Try STAT+ My Account
    • Biotech
    • Business
    • Coronavirus
    • Health
    • Health Tech
    • Hospitals
    • In the Lab
    • Insurance
    • Pharma
    • Politics & Policy
    • First Opinion
    • The Pharmalot View
    • Adam's Take
    • Matt's Take
    • Off the Charts
  • TEAM
    • Upcoming Industry Events
    • STAT Events
    • STAT Summits
  • NEWSLETTERS
    • Color Code
    • First Opinion Podcast
    • The Readout LOUD
    • STAT Trials Pulse
    • Reports
    • E-books
  • VIDEO
    • STAT+

      Exclusive analysis of biotech, pharma, and the life sciences

      Learn More
      • View Stories
      • My Account
    • Topics

      • Biotech
      • Pharma
      • Policy
      • Health Tech
      • Business
    • Columns

      • Adam's Take
      • Matt's Take
      • The Pharmalot View
    • Tools

      • CRISPR Trackr
      • Breakthrough Device Tracker
      • Drug Pricing Policy Cheat Sheet
    • Events

      • All STAT Events
    • Team

      • Biotech and Pharma
      • Health Tech
      • Politics and Policy
      • Health and Science

Account

  • My Account
  • Billing
  • Subscribe
  • Log In
  • Help

More

  • Community
  • Contribute
  • Group Subscriptions

Follow Us

Trending:
The Obesity Revolution
Health
Biotech
First Opinion
Business

Cambridge biotech firm Moderna wins Zika vaccine grant

By Dan Adams — Boston GlobeSept. 7, 2016

Reprints
RICARDO MAZALAN/AP

Cambridge biotech firm Moderna wins Zika vaccine grant

About the Author Reprints

Dan Adams — Boston Globe

Tags

vaccine

Zika Virus

Trending

Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo

Recommended

FDA advisory panel recommends conditional approval of Biogen’s drug…
FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS
The lesson biotech absolutely should not take from Silicon…
The lesson biotech absolutely should not take from Silicon Valley Bank’s failure
Senators interrogate health secretary Becerra on Alzheimer’s drug coverage
Senators interrogate health secretary Becerra on Alzheimer’s drug coverage

Recommended Stories

In the Lab Jason Mast

STAT Plus: Researchers devise new strategies to overcome a key CRISPR flaw

Politics Helen Branswell, Rachel Cohrs and Damian Garde

STAT Plus: 8 burning questions Bernie Sanders and other senators should ask Moderna’s Stéphane Bancel

advertisement

Health Tech Brittany Trang and Casey Ross

STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool

A STAT Investigation Casey Ross and Bob Herman

STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need

Biotech Adam Feuerstein, Damian Garde and Allison DeAngelis

STAT Plus: SVB, biotech’s bank of choice, just failed. It could have ripple effects

STAT

Reporting from the frontiers of health and medicine

Trending:
  • The Obesity Revolution
  • Health
  • Biotech
  • First Opinion
  • Coronavirus
  • The Readout LOUD
Back to top

Company

  • About STAT
  • Awards
  • Contact Us
  • Careers & Internships
  • Diversity & Inclusion
  • Licensing Stories
  • Our Team
  • Supporters

Account

  • About STAT+
  • FAQs
  • Log In
  • Subscribe

App & Other Products

  • STAT App
  • Newsletters
  • Podcasts
  • STAT Madness
  • STAT Reports
  • STAT Trials Pulse
  • STAT Wunderkinds

Group Subscriptions

  • Contact Us
  • Request A Quote

Advertising

  • Advertise With Us

Events

  • Upcoming Industry Events
  • STAT Events
  • STAT Summits
  • Sponsor An Event
  • Privacy
  • Comment Policy
  • Terms
  • Do Not Sell my Data
  • ©2023 STAT

You've been selected! Subscribe to STAT+ for less than $2 per day

You've been selected! STAT+ for less than $2/day

Unlimited access to essential biotech, medicine, and life sciences journalism

Start your free trial

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Unlimited access to the health care news and insights you need

Get unlimited access

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Unlimited access to essential biotech, medicine, and life sciences journalism

Start your free trial